Antibacterial and antibiofilm effects of green synthesized selenium nanoparticles on clinical Klebsiella pneumoniae isolates

Abstract

AbstractNanotechnology covers many disciplines, including the biological sciences. In this study, selenium nanoparticles (Se‐NPs) were synthesized using Artemisia annua extract and investigated against clinical strains of klebsiella pneumoniae (K. pneumoniae) for their anti‐biofilm effects. In this experimental study, from May 1998 to September 1998, 50 clinical samples of blood, urine, and sputum were collected, and K. pneumoniae strains were isolated using microbiological methods. Subsequently, the antibacterial effects of Se‐NPs at concentrations of 12‐25‐50‐100/5‐6/3‐25/125 μg/mL were studied. Finally, biofilm‐producing strains were isolated, and the expression of mrkA biofilm gene was studied in real‐time strains treated with Se‐NPs using real‐time polymerase chain reaction (PCR). Out of 50 clinical samples, 20 strains of K. pneumoniae were isolated. Minimum inhibitory concentration (MIC) results of Se‐NPs showed that Se‐NPs were capable of significant cell killing. Real‐time PCR results also showed that mrkA gene expression was significantly reduced in strains treated with Se‐NPs. According to this study, Se‐NPs could reduce bacterial growth and biofilm formation, therefore, could be considered a candidate drug in the medical application for infections caused by K. pneumoniae.